What the FDA labels say about taking them together
Acitretin and glyburide
Acitretin's FDA label of August 5, 2026 names glyburide in its drug interactions section; the glyburide label PlainMeds reads does not name acitretin.
Check it at the source: the acitretin FDA label on DailyMed (effective August 5, 2026, Sigmapharm Laboratories, LLC); the glyburide FDA label on DailyMed (effective July 1, 2021, TEVA Pharmaceuticals USA Inc).
What does the acitretin label say about glyburide?
Acitretin label, drug interactionsIn a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.
Source: FDA drug label (ACITRETIN), Sigmapharm Laboratories, LLC, effective August 5, 2026 (SPL set a6546625-acb8-460e-b34e-f795bfb3680a), via openFDA; the full label on DailyMed
What does the glyburide label say about acitretin?
Glyburide's label (effective July 1, 2021) does not name acitretin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Glyburide), NDA017532 (Sanofi Aventis Us), as published by TEVA Pharmaceuticals USA Inc, effective July 1, 2021 (SPL set 50d16f1d-c814-4411-8749-62561321ecce), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Acitretin | Glyburide | |
|---|---|---|
| Labeled for | Psoriasis | Type 2 diabetes |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $2.59 per capsule 10 mg capsule | $0.0643 per tablet 5 mg tablet |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once